Lexicon Pharmaceuticals, Inc. (LXRX) financial statements (2022 and earlier)

Company profile

Business Address 2445 TECHNOLOGY FOREST BLVD.
THE WOODLANDS, TX 77381
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments87121119141152111202
Cash and cash equivalents649290981265287
Short-term investments232929442659115
Receivables00000131
Inventory, net of allowances, customer advances and progress billings      4
Inventory      4
Other current assets2354599
Total current assets:89124123145158122246
Noncurrent Assets
Property, plant and equipment111001112
Intangible assets, net (including goodwill), including:45454545451963
Goodwill45454545454545
Intangible assets, net (excluding goodwill)      19
Other undisclosed intangible assets, net (including goodwill)     (26) 
Regulated entity, other noncurrent assets     0 
Other noncurrent assets2233111
Other undisclosed noncurrent assets     26 
Total noncurrent assets:48484848465776
TOTAL ASSETS:137172172193204179323
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22232127357087
Accounts payable989551230
Accrued liabilities13141322305857
Debt 12121212910
Total current liabilities:22343339477998
Noncurrent Liabilities
Long-term debt and lease obligation     12235
Long-term debt, excluding current maturities     12235
Liabilities, other than long-term debt1122111
Other liabilities1122111
Total noncurrent liabilities:1122112236
Total liabilities:233634414791333
Stockholders' equity
Stockholders' equity attributable to parent11413713715315688(11)
Common stock0000000
Treasury stock, value(8)(8)(8)(8)(5)(5)(5)
Additional paid in capital1,6091,6061,5841,5811,5611,4871,471
Accumulated other comprehensive income (loss)(0)(0)(0)0(0)00
Accumulated deficit(1,488)(1,462)(1,439)(1,421)(1,400)(1,395)(1,477)
Total stockholders' equity:11413713715315688(11)
TOTAL LIABILITIES AND EQUITY:137172172193204179323

Income statement (P&L) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q1
Revenues0000079
Cost of revenue
(Cost of Goods and Services Sold)
     (1)(1)
Gross profit:0000068
Operating expenses(25)(23)(18)(21)(7)(53)(74)
Other undisclosed operating income (loss)    (0)1331
Operating income (loss):(25)(23)(18)(21)(7)87(65)
Nonoperating income
(Other Nonoperating income)
0000101
Interest and debt expense(0)(0)(0)(0)1(4)(5)
Income (loss) from continuing operations before income taxes:(26)(23)(18)(21)(5)83(69)
Other undisclosed income from continuing operations    0  
Income (loss) from continuing operations:(26)(23)(18)(21)(5)83(69)
Other undisclosed loss before gain (loss) on sale of properties    (12)  
Income (loss) before gain (loss) on sale of properties:(26)(23)(18)(21)(17)83(69)
Other undisclosed net income    12  
Net income (loss) available to common stockholders, basic:(26)(23)(18)(21)(5)83(69)
Dilutive securities, effect on basic earnings per share     1 
Other undisclosed net loss available to common stockholders, diluted(88)   (59)  
Net income (loss) available to common stockholders, diluted:(113)(23)(18)(21)(64)84(69)

Comprehensive Income ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q1
Net income (loss):(26)(23)(18)(21)(5)83(69)
Comprehensive income (loss):(26)(23)(18)(21)(5)83(69)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0) (0)0(0)(0)(1)
Comprehensive income (loss), net of tax, attributable to parent:(26)(23)(18)(21)(6)82(70)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: